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ABSTRACT
Objective: The limited regenerative capacity of the cartilage tissue
makes the treatment of chondral lesions difficult. The techniques
currently available to treat cartilage lesions may relieve symptoms,
but do not regenerate the injured tissue. Autologous chondrocyte
transplantation uses cell biology and cell culture techniques to
regenerate the hyaline cartilage. Methods: In this study, we analyze
chondrocyte biopsy collection and culture for autologous
transplantation. Ultrastructural analyses of hyaline cartilage biopsies
were performed 0, 6, 24 and 48 hours after collection. The tissue even
after 48 hours. Eleven cell culture assays were performed to evaluate
isolation, viability, morphology, proliferation and absence of
contaminants. Results: The cell culture techniques used allowed
chondrocyte proliferation. Rates on cell viability were maintained above
the acceptable patterns (above 90). Control of cell culture laboratory
conditions showed absence of contaminants, assuring safety of the
process. The chondrocytes obtained presented the morphology typical
of cultured cell monolayers. Conclusion: The results indicate viability
of chondrocyte culture technique for clinical application in autologous
transplantation.
Keywords: Cell culture; Chondrocytes/transplantation; Transplantation,
autologous/methods; Cartilage
RESUMO
Objetivo: A baixa capacidade regenerativa do tecido cartilaginoso
dificulta o tratamento das lesões condrais. As técnicas disponíveis
atualmente para o tratamento de lesões de cartilagem articular
podem resultar em alívio dos sintomas, mas não na regeneração
do tecido lesado. O transplante autólogo de condrócitos utiliza
técnicas de biologia celular e cultura de células para a regeneração
da cartilagem hialina. Neste trabalho procuramos analisar a cultura
de condrócitos visando o transplante autólogo. Métodos: Foram
realizados 11 experimentos de cultura celular para avaliar os dados
de isolamento, viabilidade, morfologia, proliferação e ausência de
contaminantes. As condições de cultura celular utilizadas permi-
tiram a proliferação dos condrócitos. As taxas de viabilidade celular
se mantiveram acima de 90%. Resultados: O controle das condições
do laboratório de cultura celular demonstrou a ausência de
contaminantes, garantindo a segurança do processamento. As
células obtidas apresentaram morfologia típica de condrócitos
cultivados em monocamada. Conclusão: Os resultados obtidos
indicam a viabilidade da técnica de cultura de condrócitos para a
aplicação clínica na técnica de transplante autólogo.
Descritores: Cultura de células; Condrócitos; Transplante autólogo/
métodos; Cartilagem
INTRODUCTION
The nutrition of cartilage tissue of articular surfaces is
carried out by diffusion of substances found in the synovial
fluid. The chondrocytes present in tissues are highly
specialized and their major function is to provide
biomechanical properties, by synthesizing extracellular
matrix components. In the articular cartilage there are
proteoglycans, especially agregan, and mostly type II
collagen. The differentiated state of chondrocytes and
the absence of tissue irrigation make the repair of chondral
lesions difficult.
Tissue repair of chondral lesions is based on surgical
techniques. Their rationale is to fill in the lesion with
subchondral bone mesenchymal cells by means of abrasion,
perforation and micro fractures. However, the lesions are
filled in by fibrous tissue or fibrocartilage, which has
different features as compared with the previous hyaline
cartilage. Type I collagen prevails in the extracellular
matrix of this repair tissue. The autologous transplantation
of chondrocytes has been used as a biotechnological
alternative to treat chondral lesions resulting fromeinstein 2003; 1:84-8
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acute or repeated trauma and not responding to
previous treatments, whether surgical or clinical(1-4).
Autologous transplantation of chondrocytes is a
technique that aims at regenerating the hyaline cartilage,
restoring the function of the articular surface. This
technique has been studied since the end of the 80’s(5-6).
In 1994, a group from the University of Gothenburg and
from the Sahlgrenska University Hospital presented a pilot
study with 23 patients submitted to this technique to treat
cartilage lesions(7). Sixteen patients had lesions in the
femoral condyle and seven had patellar lesions. The cases
were followed for up to two years, and good or excellent
recovery was observed in 14 out of 16 patients with femoral
condylar lesions. Biopsy was performed in 15 patients and
hyaline cartilage similar to the original tissue was observed
in 11 of these cases.
Other scientific reports were published later(8-11).
Improving this technique encompasses the supplementation
of cell cultures with growth factors(12), the utilization of
biomaterials(13-14) and the application of bioreactor systems
to produce cartilage tissue in vitro(15).
The technique for autologous transplantation of
chondrocytes for articular cartilage regeneration (figure
1) comprises removal of a sample of normal cartilage from
a low-load region of the joint. This biopsy is properly
prepared and sent to the cell culture laboratory where
enzyme digestion is performed for cell isolation and
culture(16-17). A suspension of cultivated chondrocytes is
prepared after a period of 30 to 40 days. The injection of
cell suspension involves debridement of the chondral
lesion, covering the lesion with a layer of periosteum
usually removed from the tibia, and the injection of cell
suspension between the periosteum cover and the
subchondral bone(8).
The transplanted chondrocytes are able to reorganize
themselves to produce hyaline matrix, regenerating a
tissue with the same characteristics of the original hyaline
cartilage. The recently formed tissue is completely
integrated, filling in the entire site of the lesion and
adjacent areas(7). In the first eight weeks after
transplantation, 71% of the area, in average, is filled in
and the tissue is basically hyaline, with cell clusters and
predominance of type II collagen(8).
In the present study, we sought to improve the cell
culture technique aiming at autologous transplantation
of chondrocytes, and evaluating cell preservation,
proliferation and morphology.
METHODS
Biopsy Collection
Samples of articular cartilage were obtained from nine
patients, six men and three women, age range 23-66 years
(mean age = 48 years). Two samples were submitted to
enzyme digestion on different days, totaling 11 cell
cultures. The patients were submitted to arthroscopy for
several reasons. The cartilage samples were collected in
culture medium according to the protocol described
above including previous patient consent(7). Thermal
containers were used to transport cartilage samples so
that the temperature was kept between 4°C and 8°C.
Chondrocyte Isolation
Eleven samples of articular cartilage were taken to the
culture laboratory and submitted to enzyme digestion
process to isolate cells, according to the protocol of
Archer et al.(16)
Chondrocyte Culture
The cells from enzyme digestions were then cultivated
in culture flasks with HAMF12 medium containing
penicillin/streptomycin 1% and fetal bovine serum 10%,
for periods of up to 40 days, and the medium was
changed twice or three times per week. Cell replication
was performed as necessary.
Cell Count and Viability
Total cells and percentage of viable cells were counted,
right after cell isolation and at the end of cultures,
using trypan blue in a hemocytometric chamber.
Morphological Analyses
Morphological analyses of cells were routinely performed
using phase microscopy in an inverted microscope
(Olympus IX-50). The cultures were photographed
regularly to record cell morphology.
Microbiological Analyses
Some cell culture samples were submitted to microbiological
contamination tests. Testing for the presence of
bacteria, fungi and mycoplasmas was performed
according to ISO 11737-1 standards, 5th edition, 1995
and USP XXIII/NF XVIII, 1995.
RESULTS
Chondrocyte Isolation
Chondrocytes isolated from articular cartilage weighed
between 102 mg and 417 mg (mean weight=255 mg),
resulting in an average of 140,560 chondrocytes in 100
mg of tissue (table 1). Recently isolated chondrocyteseinstein 2003; 1:84-8
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presented rounded morphology, which is characteristic
of these cells.
Cell viability counts were performed in the eleven
samples, yielding values always above 90% (table 1).
Microbiological Analyses
All microbiological analyses performed in cell cultures
were negative, translating the absence of bacteria, fungi
or mycoplasmas in cultures.
DISCUSSION
Surgical techniques try to repair tissues based on the
principle of filling in the lesion with bone marrow
mesenchymal cells, by means of abrasion, perforations
and micro fractures. However, the cells that fill in the
chondral lesion synthesize fibrous tissue, or fibrocartilage,
and have composition and properties that differ from
those of the original hyaline tissue. In this case, type I
collagen prevails in the extracellular matrix. The
presence of fibrous tissue may cause the patient to have
pain and impaired movement in the long run. To form
hyaline articular cartilage similar to the original one,
autologous transplantation of chondrocytes is an
alternative to treat chondral lesions resulting from
acute or repetitive trauma and that have not responded
to previous surgical or clinical treatments(5-11).
In our laboratory we tested the processing conditions
of cartilage biopsies and chondrocyte culture phases
aiming at cell proliferation. We obtained fragments of
femoral condyle cartilage of different sizes and regions.
Our observations express the clinical reality, and it is
not possible to standardize collection of material. Yet,
we limited collection to the femoral condyle, always
preserving subchondral bone.
The cell isolation process proved to be efficient,
and enabled collecting many cells per 100 mg of tissue.
It is essential to obtain a minimum number of cells to
begin cultures, since we expect increased number of
cells with few culture transfers in order to preserve cell
characteristics and avoid apoptosis in autologous
transplantation. We know that after a few transfers
without culture, a cell death process may occur. Thus,
the culture process was performed respecting this limit.
The conditions of cell cultures, such as supplementation
with fetal bovine serum, assured a high cell
proliferation rate and enabled achieving a minimum
of one million cells, always with cell viability above 85%,
as described in the literature(7).
Chondrocyte morphology in culture translates the
differentiated state of cells, as expected in the
proliferative role of cultures(18-20). Cultivated chondrocytes
in monolayer cultures from some transfers acquired a
flattened morphology and had high proliferation rates.
Cell morphology is directly linked to protein synthesis.
In this differentiated state, the cells start producing
type I collagen, preferably, replacing the synthesis of
type II collagen, which is characteristic of hyaline
Table 1. Cell culture monitoring after cartilage tissue biopsy. Specimen
weight, cell count, initial and final viability values, time up to final culture
Specimen Initial Number Initial Days of Final Number Final
weight (mg)  of Cells  Viability (%)  Culture  of Cells  Viability (%)
154 100,000 100 28 6,000,000 —
294 11,000 50 33 1,000,000 —
514 53,000 — 31 11,000,000 —
310 84,000 — 13 18,000,000 95
292 93,000 100 27 3,000,000 94
184 41,000 90 56 9,500,000 93
224 245,000 96 25 10,000,000 —
417 135,000 96 24 3,300,000 —
102 153,000 93 36 1,200,000 94
400 85,000 96 42 18,800,000 96
300 73,000 98 — — —
Chondrocyte Culture
Chondrocytes were kept in culture from 13 to 56 days
in order to reach at least one million cells, resulting in
an average of 31.5 days of culture. The total number
of cells and their viability were counted to conclude
the cultures. The values obtained for cell viability were
above 90%. The final number of cells ranged from
1,200,000 to 18,800,000, resulting in an average of
8,500,000 cells, that is, a 23.7-fold increase in the
number of cells (table 1).
Morphological Analyses
Cell adhesion and spreading processes on the polypropylene
surface during cell culture resulted in change in the
rounded shape characteristic of chondrocytes. After
three to five days of culture, flattened and spread
chondrocytes with typical fibroblast morphology could
be seen (figure 2). Images of cell division were
frequently present in cultures (figure 2D). Despite the
elongated morphology, evident signs of cell degeneration
or apoptosis were not observed, as proven by the final
cell viability count.einstein 2003; 1:84-8
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A. Articular cartilage
biopsy.
B. Laboratory phase for isolation, culture and
proliferation of chondrocytes.
C. Debridement of
chondral lesion.
D. Removal of
periosteum to cover
chondral lesion.
E. Injection of cell
suspension under
periosteum cover.
A B
C D
Figure 1. Autologous chondrocyte transplantation for articular cartilage regeneration. First, a cartilage specimen is
excised form a region not submitted to load of the joint (A); later the biopsy specimen is taken to the cell culture
laboratory where chondrocyte isolation and culture are performed (B). The cell suspension resulting from this
process is sent for transplantation. The lesion should be debrided (C), and covered with periosteum (D) for cell
suspension injection (E).
Figure 2. Phase microscopy (A). Recently isolated chondrocytes with characteristic rounded morphology
are observed (B). Culture in semi-confluent monolayer, 8-day culture (C). Culture in confluent monolayer,
33-day culture (D). Cell division in 35-day culture. Bar: 100 µm.einstein 2003; 1:84-8
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cartilage. After some transfers it is possible to
reestablish the normal chondrocyte phenotype as long
as there are ideal conditions for cell re-differentiation(21-23).
The fact that cells are implanted in hyaline substrate
with characteristic extracellular matrix works as a sign
of cell differentiation in autologous transplantation
of chondrocytes. Once implanted, chondrocytes are
able to express their normal phenotype and synthesize
extracellular matrix. We did not observe intense
extracellular matrix synthesis in our cultures, because
the target was to obtain a high cell proliferation rate.
The absence of contaminants in all cultures tested
(according to quality control requirements of regulatory
agencies) is an evidence of safe working conditions.
The results in the present study enabled evaluation
of biopsy processing conditions to obtain chondrocytes
and of culture conditions for cell proliferation. We
could conclude that chondrocyte culture for autologous
transplantation in our environment is a possible,
feasible and safe technique for clinical application as
a surgical technique of articular cartilage regeneration.
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